QUMAVI Trademark
Trademark Overview
On Tuesday, September 9, 2025, a trademark application was filed for QUMAVI with the United States Patent and Trademark Office. The USPTO has given the QUMAVI trademark a serial number of 99382830. The federal status of this trademark filing is REGISTERED as of Tuesday, June 9, 2026. This trademark is owned by Glaxo Group Limited. The QUMAVI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives
General Information
| Serial Number | 99382830 |
| Word Mark | QUMAVI |
| Filing Date | Tuesday, September 9, 2025 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, June 9, 2026 |
| Registration Number | 8291250 |
| Registration Date | Tuesday, June 9, 2026 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 21, 2026 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, September 9, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Glaxo Group Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 77 - NOT AVAILABLE |
| Address | Stevenage SG12NY
GB |
| Party Name | Glaxo Group Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 77 - NOT AVAILABLE |
| Address | Stevenage SG12NY
GB |
| Party Name | Glaxo Group Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 77 - NOT AVAILABLE |
| Address | Stevenage SG12NY
GB |
Trademark Events
| Event Date | Event Description |
| Tuesday, September 9, 2025 | NEW APPLICATION ENTERED |
| Tuesday, September 9, 2025 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, September 9, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, January 22, 2026 | ASSIGNED TO EXAMINER |
| Friday, January 23, 2026 | NON-FINAL ACTION WRITTEN |
| Friday, January 23, 2026 | NON-FINAL ACTION E-MAILED |
| Friday, January 23, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, March 23, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, March 23, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, March 23, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, March 24, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 15, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 21, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 21, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 9, 2026 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, June 9, 2026 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
